GTP cyclohydrolase 1 Blocking Peptide
Catalog no. P-GTPCH1.2 · Research Use Only
$155 per 250 µg. Ships within 2–3 business days from the U.S.
P-GTPCH1.2 — affinity-purified Rabbit antibody against GTP cyclohydrolase 1. Validated for Immunodepletion, Immunocompetition.
Specifications
| Catalog number | P-GTPCH1.2 |
|---|---|
| Target | GTP cyclohydrolase 1 |
| Applications | Immunodepletion, Immunocompetition |
| Conjugate | Unconjugated |
| Immunogen | Synthetic peptide taken within amino acid region 25-75 on mouse GTPCHI protein. |
| Size | 250 µg |
| Storage | -20°C |
| UniProt | Q05915 |
About this target
Antigenic blocking peptide for the FabGennix GTP cyclohydrolase 1 rabbit polyclonal antibodies (GTPCH1-101AP, GTPCH1-112AP, NACR-101AP). Pre-incubating the antibody with this peptide before staining is a standard competition control to confirm that the signal is specific to the target. Positively regulates nitric oxide synthesis in endothelial cells. Invovled in dopamine synthesis and pain sensitivity and persistence. Toroid-shaped homodecamer. Composed of two pentamers of five dimers. Subcellular location: Cytoplasm; Nucleus.
Documents
Related products
- GTP cyclohydrolase 1 Antibody (GTPCH1-101AP)
- GTP cyclohydrolase 1 Antibody (GTPCH1-112AP)
- GTP cyclohydrolase 1 Antibody BIOTIN (GTPCH1.1-BIOTIN)
- GTP cyclohydrolase 1 Antibody FITC (GTPCH1.1-FITC)
- GTP cyclohydrolase 1 Antibody BIOTIN (GTPCH1.2-BIOTIN)
- GTP cyclohydrolase 1 Antibody FITC (GTPCH1.2-FITC)
- Nicotinic Acetylcholine Receptor alpha 7 subunit 2 (NACR-101AP)
- Nicotinic Acetylcholine Receptor alpha 7 Antibody BIOTIN (NACR-BIOTIN)
- Nicotinic Acetylcholine Receptor alpha 7 Antibody FITC (NACR-FITC)
- GTP cyclohydrolase 1 Blocking Peptide (P-GTPCH1.1)
- Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (P-NACR)
- GTP cyclohydrolase 1 Positive Control (PC-GTPCH1)
- Nicotinic Acetylcholine Receptor alpha 7 Positive Control (PC-NACR)
FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.